Cambrex Profarmaco Milano Srl
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Italy
- Registered address
- VIA EUGENIO CURIEL 34, PAULLO, MILANO 20067, Italy (ITA)
- Operations here
- analysisapi manufacture
- FDA identifiers
- FEI 3003723076 · DUNS 438051401
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIDrug Quality Assurance2022-11-11
- VAIDrug Quality Assurance2021-10-01
- NAIDrug Quality Assurance2019-05-07
- VAIDrug Quality Assurance2017-05-19
- VAIDrug Quality Assurance2015-11-06
- NAIDrug Quality Assurance2011-03-25
- OAIDrug Quality Assurance2009-03-31
Drugs this plant is listed as making
1 distinct drugs across 2 products name this site in their FDA label.
- irbesartan and hydrochlorothiazideSanofi-Aventis U.S. LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.